Literature DB >> 14633854

Brain death significantly reduces isolated pancreatic islet yields and functionality in vitro and in vivo after transplantation in rats.

Juan L Contreras1, Christopher Eckstein, Cheryl A Smyth, Marty T Sellers, Mario Vilatoba, Guadalupe Bilbao, Firoz G Rahemtulla, Carlton J Young, J Anthony Thompson, Irshad H Chaudry, Devin E Eckhoff.   

Abstract

Although approximately 1 million islets exist in the adult human pancreas, current pancreas preservation and islet isolation techniques recover <50%. Presently, cadaveric donors remain the sole source of pancreatic tissue for transplantation. Brain death is characterized by activation of proinflammatory cytokines and organ injury during preservation and reperfusion. In this study, we assessed the effects of brain death on islet isolation yields and functionality. Brain death was induced in male 250- to 350-g Lewis rats by inflation of a Fogarty catheter placed intracranially. The rats were mechanically ventilated for 2, 4, and 6 h before removal of the pancreas (n = 6). In controls, the catheter was not inflated (n = 6). Shortly after brain death induction, a significant increase in serum tumor necrosis factor-alpha (TNF-alpha), interleukin (IL)-1beta, and IL-6 was demonstrated in a time-dependent manner. Upregulation of TNF-alpha, IL-1beta, and IL-6 mRNA was noted in the pancreas. Brain death donors presented lower insulin release after glucose stimulation assessed by in situ perfusion of the pancreas. Islet recovery was reduced in brain death donors compared with controls (at 6 h 602.3 +/- 233.4 vs. 1,792.5 +/- 325.4 islet equivalents, respectively; P < 0.05). Islet viability assessed in dissociated islet cells and in intact cultured islets was reduced in islets recovered from brain death donors, an effect associated with higher nuclear activities of NF-kappaB p50, c-Jun, and ATF-2. Islet functionality evaluated in vitro by static incubation and in vivo after intraportal transplantation in syngeneic streptozotocin-induced diabetic rats was significantly reduced in preparations obtained from brain death donors. In conclusion, brain death significantly reduced islet yields and functionality. These observations may lead to strategies to reduce the effects of brain death on pancreatic islets and improve the results in clinical transplantation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14633854     DOI: 10.2337/diabetes.52.12.2935

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  35 in total

Review 1.  Ischaemia is linked to inflammation and induction of angiogenesis in pancreatic islets.

Authors:  T Linn; J Schmitz; I Hauck-Schmalenberger; Y Lai; R G Bretzel; H Brandhorst; D Brandhorst
Journal:  Clin Exp Immunol       Date:  2006-05       Impact factor: 4.330

2.  The synthetic liver X receptor agonist GW3965 reduces tissue factor production and inflammatory responses in human islets in vitro.

Authors:  H Scholz; T Lund; M K Dahle; J L Collins; O Korsgren; J E Wang; A Foss
Journal:  Diabetologia       Date:  2009-05-05       Impact factor: 10.122

3.  Human islet preparations distributed for research exhibit a variety of insulin-secretory profiles.

Authors:  Nora S Kayton; Gregory Poffenberger; Joseph Henske; Chunhua Dai; Courtney Thompson; Radhika Aramandla; Alena Shostak; Wendell Nicholson; Marcela Brissova; William S Bush; Alvin C Powers
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-02-03       Impact factor: 4.310

4.  Donor Pretreatment With IL-1 Receptor Antagonist Attenuates Inflammation and Improves Functional Potency in Islets From Brain-Dead Nonhuman Primates.

Authors:  Juan S Danobeitia; Matthew S Hanson; Peter Chlebeck; Elisa Park; Jamie M Sperger; Alice Schwarznau; Luis A Fernandez
Journal:  Cell Transplant       Date:  2014-04-22       Impact factor: 4.064

5.  Evidence of stress in β cells obtained with laser capture microdissection from pancreases of brain dead donors.

Authors:  Aref Ebrahimi; Min-Ho Jung; Jonathan M Dreyfuss; Hui Pan; Dennis Sgroi; Susan Bonner-Weir; Gordon C Weir
Journal:  Islets       Date:  2017-03-04       Impact factor: 2.694

6.  P38alpha-selective mitogen-activated protein kinase inhibitor for improvement of cultured human islet recovery.

Authors:  Keiko Omori; Ivan Todorov; Jonathan Shintaku; Jeffrey Rawson; Ismail H Al-Abdullah; Linda S Higgins; Satyanarayana Medicherla; Fouad Kandeel; Yoko Mullen
Journal:  Pancreas       Date:  2010-05       Impact factor: 3.327

Review 7.  Can cells and biomaterials in therapeutic medicine be shielded from innate immune recognition?

Authors:  Bo Nilsson; Olle Korsgren; John D Lambris; Kristina Nilsson Ekdahl
Journal:  Trends Immunol       Date:  2010-01       Impact factor: 16.687

8.  Redox modulation protects islets from transplant-related injury.

Authors:  Martha M Sklavos; Suzanne Bertera; Hubert M Tse; Rita Bottino; Jing He; Joshua N Beilke; Marilyne G Coulombe; Ronald G Gill; James D Crapo; Massimo Trucco; Jon D Piganelli
Journal:  Diabetes       Date:  2010-04-22       Impact factor: 9.461

9.  A stirred microchamber for oxygen consumption rate measurements with pancreatic islets.

Authors:  Klearchos K Papas; Anna Pisania; Haiyan Wu; Gordon C Weir; Clark K Colton
Journal:  Biotechnol Bioeng       Date:  2007-12-01       Impact factor: 4.530

10.  Pancreatic islet transplantation.

Authors:  Maria Lúcia Corrêa-Giannella; Alexandre S Raposo do Amaral
Journal:  Diabetol Metab Syndr       Date:  2009-09-21       Impact factor: 3.320

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.